From Hacker News · · 1 min
Inside RonanRx: Software-Driven Custom GLP-1 Manufacturing
RonanRx is vertically integrating telehealth, software, and drug compounding to deliver personalized, affordable GLP-1 treatments.
In brief
RonanRx is vertically integrating telehealth, software, and drug compounding to deliver personalized, affordable GLP-1 treatments. Combining vertical manufacturing with real-time doctor feedback loops enables hyper-personalized, lower-cost pharmaceutical care. Originally reported by Hacker News.
From mask factories to medicine
After building a $50M automated mask manufacturing business during the pandemic, founder Lloyd Armbrust pivoted to solving disconnected pharmaceutical supply chains using software.
“We took a software approach to building our factory.”
The life-changing power of GLP-1s
Armbrust tried tirzepatide for weight loss and eliminated compulsive behaviors. Most surprisingly, the drug delayed his required open-heart surgery by decades.
“After just 18 months using tirzepatide, my cardiologist’s began to think my surgery could be pushed back until I am 70 or 80.”
Fragmented healthcare creates rigid dosing
Traditional pharmaceuticals sell fixed doses despite patients processing drugs differently. Telehealth, prescribing, manufacturing, and delivery operate in isolated silos.
“GLP-1s come in a handful of predefined doses, but patients obviously aren't standardized.”
Owning the entire pharmaceutical stack
RonanRx unifies telehealth, prescribing, compounding, manufacturing, and delivery into a single software-driven system.
“The thing that bothered me was how disconnected all of the pieces were: telehealth, EHR, prescriptions, dispensing software, production, shipping.”
A weekly feedback loop for dosing
By integrating wearable data, lab results, and patient side-effect logs, physicians can dynamically adjust custom micro-doses every week.
“As the patient is undergoing treatment, their response becomes data that can be used by their doctor to modify the treatment.”
Making GLP-1s dramatically more affordable
Starting from raw active molecules and manufacturing drugs in-house cuts out middlemen, reducing prices by 3x to 10x compared to traditional brand-name sources.
“Because people can buy directly from us, their price is usually 3x-10x more affordable.”
Navigating compounding pharmacy laws
Federal 503a compounding pharmacy regulations protect custom formulations. Continuous clinician-led personalization ensures full regulatory compliance while tailoring dosages.
“The legal cutout that we have is on the personalization front, which is very well protected.”
The future of patient-specific drugs
Starting with weight-loss peptides is just the first phase. RonanRx aims to build scalable infrastructure for custom, patient-specific drug manufacturing across medicine.
“We are more interested in the potential of patient-specific pharmaceutical manufacturing.”
The big picture
Combining vertical manufacturing with real-time doctor feedback loops enables hyper-personalized, lower-cost pharmaceutical care.
